Abstract: OBJECTIVE To explore the therapeutic regimen for pneumonia fusarium and the role of clinical pharmacists during treatment.METHODS The clinical pharmacist participated in the pharmaceutical care involved in one case of pneumonia infection due to Fusarium. By reviewing related domestic and foreign litetatures, the clinical pharmacist assisted the clinician to develop the medication regimen based on the in vitro antifungal susceptibility of Fusarium species and clinical effect.RESULTS Clinicians adopted this recommendation, the patient's condition improved significantly after treatment, no severe adverse events occurred, and the patient was discharged.CONCLUSION Clinical pharmacists involving in individual medication regimen for patients can guarantee their medication safety, as well as improving pharmacotherapy level.